ALDER BIOPHARMACEUTICALS INC's ticker is ALDR and the CUSIP is 014339105. A total of 135 filers reported holding ALDER BIOPHARMACEUTICALS INC in Q3 2015. The put-call ratio across all filers is 2.83 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2019 | $566,000 | +62.2% | 30,017 | +17.3% | 0.01% | +25.0% |
| Q1 2019 | $349,000 | -12.5% | 25,596 | -34.3% | 0.00% | -20.0% |
| Q4 2018 | $399,000 | -46.4% | 38,953 | -12.9% | 0.01% | -44.4% |
| Q3 2018 | $745,000 | +97.1% | 44,735 | +86.7% | 0.01% | +80.0% |
| Q2 2018 | $378,000 | -80.9% | 23,955 | -84.6% | 0.01% | -83.9% |
| Q1 2018 | $1,978,000 | +451.0% | 155,711 | +396.6% | 0.03% | +416.7% |
| Q4 2017 | $359,000 | -21.8% | 31,358 | +125.6% | 0.01% | -88.0% |
| Q4 2015 | $459,000 | +37.4% | 13,900 | +120.6% | 0.05% | -53.7% |
| Q2 2015 | $334,000 | – | 6,300 | – | 0.11% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Foresite Capital Management III, LLC | 2,942,130 | $37,365,000 | 8.14% |
| Foresite Capital Management II, LLC | 1,686,220 | $21,415,000 | 7.12% |
| Foresite Capital Management IV, LLC | 830,919 | $10,553,000 | 4.38% |
| SENZAR ASSET MANAGEMENT, LLC | 822,890 | $10,451,000 | 3.30% |
| Redmile Group, LLC | 6,505,766 | $82,623,000 | 3.19% |
| DAFNA Capital Management LLC | 396,013 | $5,029,000 | 2.45% |
| SECTORAL ASSET MANAGEMENT INC | 863,600 | $10,968,000 | 1.20% |
| Palo Alto Investors LP | 1,849,832 | $23,493,000 | 1.00% |
| Bellevue Group AG | 700,464 | $8,896,000 | 0.88% |
| Rock Springs Capital Management LP | 1,529,800 | $19,428,000 | 0.83% |